BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 27086821)

  • 1. Laryngeal Kaposi's Sarcoma Complicated by the Immune Reconstitution Inflammatory Syndrome in an HIV-infected Patient.
    Kato H; Yanagisawa N; Morioka H; Sasaki S; Sekiya N; Suganuma A; Imamura A; Ajisawa A
    Intern Med; 2016; 55(8):1001-5. PubMed ID: 27086821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful treatment of an HIV-positive patient with unmasking Kaposi's sarcoma immune reconstitution inflammatory syndrome.
    Speicher DJ; Sehu MM; Johnson NW; Shaw DR
    J Clin Virol; 2013 Jul; 57(3):282-5. PubMed ID: 23578530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of severe or progressive Kaposi's sarcoma in HIV-infected adults.
    Gbabe OF; Okwundu CI; Dedicoat M; Freeman EE
    Cochrane Database Syst Rev; 2014; (9):CD003256. PubMed ID: 25313415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histological evidence for the cardiac safety of high-dose pegylated liposomal doxorubicin in a patient with HIV-associated Kaposi sarcoma: a case report and literature review.
    Ishihara A; Hatakeyama S; Suzuki J; Amano Y; Sasahara T; Toshima M; Morisawa Y
    BMC Infect Dis; 2019 Oct; 19(1):848. PubMed ID: 31615436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human immunodeficiency virus-associated Kaposi sarcoma as an immune reconstitution inflammatory syndrome: a literature review and case report.
    Feller L; Anagnostopoulos C; Wood NH; Bouckaert M; Raubenheimer EJ; Lemmer J
    J Periodontol; 2008 Feb; 79(2):362-8. PubMed ID: 18251652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Successful Treatment of Immune Reconstitution Inflammatory Syndrome with Corticosteroid for Patient with Kaposi's Sarcoma Extending into the Respiratory Tract and Both Lungs].
    Shikawa T; Yanagisawa K; Ogawa Y; Uchiumi H; Gohda F; Handa H
    Kansenshogaku Zasshi; 2017 Jan; 91(1):25-30. PubMed ID: 30277684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune reconstitution inflammatory syndrome of Kaposi's sarcoma in an HIV-infected patient.
    Lu CL; Chang SY; Tseng YT; Wu BR; Liu WC; Hsieh CY; Wu PY; Sun HY; Hung CC
    J Microbiol Immunol Infect; 2013 Aug; 46(4):309-12. PubMed ID: 22503798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Facing up to the ongoing challenge of Kaposi's sarcoma.
    Robey RC; Bower M
    Curr Opin Infect Dis; 2015 Feb; 28(1):31-40. PubMed ID: 25490104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term prognosis of HIV-infected patients with Kaposi sarcoma treated with pegylated liposomal doxorubicin.
    Martín-Carbonero L; Palacios R; Valencia E; Saballs P; Sirera G; Santos I; Baldobí F; Alegre M; Goyenechea A; Pedreira J; González del Castillo J; Martínez-Lacasa J; Ocampo A; Alsina M; Santos J; Podzamczer D; González-Lahoz J;
    Clin Infect Dis; 2008 Aug; 47(3):410-7. PubMed ID: 18582203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pediatric Kaposi's sarcoma associated with immune reconstitution inflammatory syndrome.
    Silva L; Azurara L; Monteiro AF; Miroux-Catarino A; Amaro C; Viana I
    Pediatr Dermatol; 2020 Jan; 37(1):239-240. PubMed ID: 31755571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intralesional bevacizumab in patients with human immunodeficiency virus-associated Kaposi's sarcoma in the upper airway.
    Ablanedo-Terrazas Y; Alvarado-de la Barrera C; Ormsby CE; Ruiz-Cruz M; Reyes-Terán G
    Laryngoscope; 2015 Apr; 125(4):E132-7. PubMed ID: 25345840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triple secondary neoplasms: penis, lip and oral cavity in an AIDS patient treated with pegylated liposomal doxorubicin for cutaneous Kaposi's sarcoma.
    Volkow P; Lizano M; Carrillo-García A; Pérez-Montiel D; Garciadiego P
    AIDS; 2014 Sep; 28(15):2327-9. PubMed ID: 25313589
    [No Abstract]   [Full Text] [Related]  

  • 13. Disseminated classic Kaposi's sarcoma. Two cases with excellent response to pegylated liposomal doxorubicin.
    Castiñeiras I; Almagro M; Rodríguez-Lozano J; Fernández-Jorge B; Paradela S; Pozo JD; Fonseca E
    J Dermatolog Treat; 2006; 17(6):377-80. PubMed ID: 17853313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of pegylated lyposomal doxorubicin (PLD) in systemic Kaposi's sarcoma: a systematic review.
    Di Trolio R; Di Lorenzo G; Delfino M; De Placido S
    Int J Immunopathol Pharmacol; 2006; 19(2):253-63. PubMed ID: 16831292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of HIV-1-associated Kaposi's sarcoma with pegylated liposomal doxorubicin and HAART simultaneously induces effective tumor remission and CD4+ T cell recovery.
    Lichterfeld M; Qurishi N; Hoffmann C; Hochdorfer B; Brockmeyer NH; Arasteh K; Mauss S; Rockstroh JK;
    Infection; 2005 Jun; 33(3):140-7. PubMed ID: 15940415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapy of special HIV-associated diseases: HCV-HIV-co-infection and AIDS-related Kaposi's sarcoma - official satellite to the 7th European Conference on Clinical Aspects and Treatment of HIV-infection, October 23, 1999 in Lisbon, Portugal.
    Goebel FD; Jablonowski H
    Eur J Med Res; 1999 Dec; 4(12):507-13. PubMed ID: 10611054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, double-blind study of pegylated liposomal doxorubicin for the treatment of AIDS-related Kaposi's sarcoma.
    Cooley T; Henry D; Tonda M; Sun S; O'Connell M; Rackoff W
    Oncologist; 2007 Jan; 12(1):114-23. PubMed ID: 17227906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advanced Kaposi's sarcoma in a 2-year-old child.
    Feiterna-Sperling C; Anagnostopoulos I; Hofmann J; Krüger R
    Lancet Infect Dis; 2018 Mar; 18(3):356. PubMed ID: 29485096
    [No Abstract]   [Full Text] [Related]  

  • 19. Do we still need chemotherapy for AIDS-associated Kaposi's sarcoma?
    Dalla Pria A; Hayward K; Bower M
    Expert Rev Anticancer Ther; 2013 Feb; 13(2):203-9. PubMed ID: 23406561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liposomal pegylated doxorubicin versus low-dose recombinant interferon Alfa-2a in the treatment of advanced classic Kaposi's sarcoma; retrospective analysis of three German centers.
    Kreuter A; Rasokat H; Klouche M; Esser S; Bader A; Gambichler T; Altmeyer P; Brockmeyer NH
    Cancer Invest; 2005; 23(8):653-9. PubMed ID: 16377582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.